Pro-Larva – the new medical grade anti-viral mask

  • The 4 ply anti-viral disposable medical mask from Pharm2Farm Ltd is proven to kill up to 99.9% of influenza and coronaviruses for up to 7 hours*.
  • Splash resistant with a melt blown filter and hypoallergenic layers, Pro-Larva uses our proprietary α-virion™ virucidal technology, featuring copper nanoparticles.
  • Pro-Larva is CE marked and is produced under sterile conditions. Its α-virion™ layer has been certified to ISO 18184 standards.
  • ISO 18184 is a standard protocol to quantify the antiviral properties of textile materials. *Within 5 minutes of contact, clinically proven by Virology Research Services Ltd, independent UK virology centre

Pharm2farm uses a patented process for producing and functionalising nanoparticles for various applications including human, animal and crop health. Pharm2farm is a wholly owned subsidiary of Remote Monitored Systems (LON:RMS).

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
Twitter
LinkedIn

More articles like this

Face masks are back for many Americans

Face mask requirements are returning to the United States in some communities and workplaces, along with directives for mandatory coronavirus vaccinations, in a new push to curb the easily transmissible delta variant of the infection that

Face masks sales soar after fears rise amidst Freedom Day

Freedom day has arrived… But despite the lifting of Covid restrictions, many experts are warning that Coronavirus infections will continue to rise. Professor Neil Ferguson, from Imperial College London and a member of the Scientific Advisory Group for Emergencies

RMS signs agreement with PIC Consultants

Remote Monitored Systems has announced that it has signed an agreement with PIC Consultants Ltd. to supply high quality retail hydroponic nutrients for distribution in the UK market. The London-listed tech company said that under the

Remote Monitored Systems signs hydroponics agreement

Remote Monitored Systems PLC announced on Monday that it has signed an agreement with PIC Consultants Ltd. to supply high quality retail hydroponic nutrients for distribution in the UK market. The London-listed tech company said that

Remote Monitored Systems growing revenues of £104k

Remote Monitored Systems plc (LON:RMS) has announced its final results for the year end 31 December 2020. Company Highlights Financials • Growing revenues of £104k (2019: £52k) • Losses increased to £1.53m (2019: £0.59m) including share